open access

Vol 49, No 1 (2017)
Letters to editor
Published online: 2017-03-31
Submitted: 2017-02-20
Accepted: 2017-03-31
Get Citation

Commentary to the article “Neuromuscular blockade in the elderly”

Paweł Twardowski, Michał Domżalski
DOI: 10.5603/AIT.2017.0012
·
Pubmed: 28362035
·
Anaesthesiol Intensive Ther 2017;49(1):75-76.

open access

Vol 49, No 1 (2017)
Letters to editor
Published online: 2017-03-31
Submitted: 2017-02-20
Accepted: 2017-03-31

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Commentary to the article “Neuromuscular blockade in the elderly”

Journal

Anaesthesiology Intensive Therapy

Issue

Vol 49, No 1 (2017)

Pages

75-76

Published online

2017-03-31

DOI

10.5603/AIT.2017.0012

Pubmed

28362035

Bibliographic record

Anaesthesiol Intensive Ther 2017;49(1):75-76.

Authors

Paweł Twardowski
Michał Domżalski

References (14)
  1. Stankiewicz-Rudnicki M. Neuromuscular blockade in the elderly. Anaesthesiol Intensive Ther. 2016; 48(4): 257–260.
  2. Sajayan A, Wicker J, Ungureanu N, et al. Current practice of rapid sequence induction of anaesthesia in the UK - a national survey. Br J Anaesth. 2016; 117 Suppl 1: i69–i74.
  3. Della Rocca G, Di Marco P, Beretta L, et al. Do we need to use sugammadex at the end of a general anesthesia to reverse the action of neuromuscular bloking agents? Position Paper on Sugammadex use. Minerva Anestesiol. 2013; 79(6): 661–666.
  4. Matteo RS, Ornstein E, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg. 1993; 77(6): 1193–1197.
  5. Varrique RM, Lauretti GR, Matsumoto JA, et al. Pharmacokinetics and pharmacodynamics of rocuronium in young adult and elderly patients undergoing elective surgery. J Pharm Pharmacol. 2016; 68(11): 1351–1358.
  6. Brueckmann B, Sasaki N, Grobara P, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth. 2015; 115(5): 743–751.
  7. McDonagh DL, Benedict PE, Kovac AL, et al. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients. Anesthesiology. 2011; 114(2): 318–329.
  8. Suzuki T, Kitajima O, Ueda K, et al. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients. Br J Anaesth. 2011; 106(6): 823–826.
  9. Yazar E, Yılmaz C, Bilgin H, et al. A Comparision of the Effect of Sugammadex on the Recovery Period and Postoperative Residual Block in Young Elderly and Middle-Aged Elderly Patients. Balkan Med J. 2016; 33(2): 181–187.
  10. Shin S, Han DW, Lee HS, et al. Elderly Patients Require Higher Doses of Sugammadex for Rapid Recovery from Deep Neuromuscular Block. Basic Clin Pharmacol Toxicol. 2016; 118(6): 462–467.
  11. Oh CS, Rhee KaY, Yoon TG, et al. Postoperative Delirium in Elderly Patients Undergoing Hip Fracture Surgery in the Sugammadex Era: A Retrospective Study. Biomed Res Int. 2016; 2016: 1054597.
  12. Siddiqi N, Harrison JK, Clegg A, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2016; 3: CD005563.
  13. Kotake Y, Ochiai R, Suzuki T, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg. 2013; 117(2): 345–351.
  14. Iwasaki H, Takahoko K, Otomo S, et al. A temporary decrease in twitch response following reversal of rocuronium-induced neuromuscular block with a small dose of sugammadex in a pediatric patient. J Anesth. 2014; 28(2): 288–290.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, Świętokrzyska 73 St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl